Neutralizing Antibody Seroprevalence Study With a Retrospective Component in Participants With Late-Onset Pompe Disease

NCT03893240 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

61

Enrollment

INDUSTRY

Sponsor class

Conditions

Pompe Disease
Pompe Disease (Late-onset)
Glycogen Storage Disease Type 2
LOPD
Lysosomal Storage Diseases
Acid Maltase Deficiency

Interventions

DIAGNOSTIC_TEST: Neutralizing Antibody to SPK-3006 capsid

Sponsor

Spark Therapeutics, Inc.